1
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Argmine Vasopressin in Hypertensive Human Pregnancy

, , &
Pages 253-269 | Published online: 07 Jul 2009
 

Abstract

Plasma concentrations of arginine vasopressin (PAVP) and its renal tubular effects were determined in 33 normotensive primigravidae, 20 primigravidae with pregnancy-associated hypertension (P-AH) and 20 subjects with chronic, presumably essential hypertension (CH). PAVP' plasma osmolality (Poan), urine osmolality and urine volume were not significantly different amongst groups but the plasma volutie (Pvap) was contracted (p < 0.001) in those with P-AH. There was no apparent relationship between P^vp and diastolic blood pressure, proteinuria or PVCL, but PAVP and Posm were significantly correlated in normotensive subjects (r = 0.52, p < 0.01) and in those with P-AH (r = 0.54, p lt; 0.05). In a separate study, there was no difference in PAVP measured under conditions of normal hydration during the second trimester, between eight primigravidae who developed P-AH in the third trimester and 48 who remained normotensive throughout pregnancy. These results demonstrate that there is no change in the plasma concentration of, or renal tubular sensitivity to, AVP in either P-AH or CH, and it is unlikely that this hormone plays a role in the development or maintenance of the hypertensive disorders of pregnancy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.